Arcadia Biosciences P/E 2024

Arcadia Biosciences Aktienanalyse

What does Arcadia Biosciences do?

Arcadia Biosciences, Inc. is a California-based company specializing in agricultural biotechnology. The company was founded in 2002 with the goal of improving and making agriculture more sustainable. Arcadia Biosciences focuses on developing plants that are more resistant to external influences such as drought or diseases, resulting in higher yields. In 2003, Arcadia Biosciences entered into a partnership with Monsanto, one of the world's largest producers of pesticides and seeds. This partnership aimed to advance the development of plants that require less pesticides and water, enabling more sustainable agricultural production. In 2008, Arcadia Biosciences acquired seed producer IPFRI, increasing production capacity and accelerating the development of new plant varieties. In 2014, the company went public on the NASDAQ stock exchange under the ticker symbol RKDA. Since then, Arcadia Biosciences has formed additional partnerships and expanded its product range. The company's core business involves developing plant varieties that are resistant to diseases and environmental influences. Arcadia Biosciences utilizes a combination of genetic and conventional breeding methods to modify the genetic makeup of plants, enhancing or weakening certain traits. This approach allows for the development of plants that are less susceptible to pests or heat. As a partner to farmers and food manufacturers, Arcadia Biosciences also provides consulting and training to promote more sustainable agricultural production. Arcadia Biosciences is divided into three business segments: 1. Arcadia Specialty Genomics: This segment specializes in the development of plants with specific traits, such as higher nutrient content or enhanced resistance to diseases. 2. GoodWheat: Under this brand, Arcadia Biosciences sells wheat products that offer a healthier alternative to conventional wheat products due to their ingredients, such as higher fiber or protein content. 3. Hemp: This segment focuses on the development of hemp products, including oil-rich seeds or hemp seeds as superfoods. Arcadia Biosciences offers a variety of products aimed at improving agricultural production and nutrition. Some examples include NitroBoost, a fertilizer that reduces nitrogen loss and improves nutrient uptake in plants; GoodWheat flour, which contains more fiber and protein than conventional wheat flour and is suitable for baking and cooking; ArcaTech, a technology designed to facilitate crop cultivation in areas with limited access to water and nutrients; and hemp seeds, which are rich in essential fatty acids and proteins. In conclusion, Arcadia Biosciences is a company specializing in agricultural biotechnology. Through the development of plants that are resistant to diseases and environmental influences, the company aims to enable more sustainable agricultural production. Arcadia Biosciences has established itself as an important player in the agricultural industry through partnerships and product development. Arcadia Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Arcadia Biosciences's P/E Ratio

The Price to Earnings (P/E) Ratio of Arcadia Biosciences is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Arcadia Biosciences's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Arcadia Biosciences is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Arcadia Biosciences’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Arcadia Biosciences stock

What is the price-to-earnings ratio of Arcadia Biosciences?

The price-earnings ratio of Arcadia Biosciences is currently -1.83.

How has the price-earnings ratio of Arcadia Biosciences changed compared to last year?

The price-to-earnings ratio of Arcadia Biosciences has increased by 335.71% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Arcadia Biosciences high compared to other companies?

Yes, the price-to-earnings ratio of Arcadia Biosciences is high compared to other companies.

How does an increase in the price-earnings ratio of Arcadia Biosciences affect the company?

An increase in the price-earnings ratio of Arcadia Biosciences would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Arcadia Biosciences affect the company?

A decrease in the price-earnings ratio of Arcadia Biosciences would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Arcadia Biosciences?

Some factors that influence the price-earnings ratio of Arcadia Biosciences are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Arcadia Biosciences pay?

Over the past 12 months, Arcadia Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Arcadia Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Arcadia Biosciences?

The current dividend yield of Arcadia Biosciences is .

When does Arcadia Biosciences pay dividends?

Arcadia Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Arcadia Biosciences?

Arcadia Biosciences paid dividends every year for the past 0 years.

What is the dividend of Arcadia Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Arcadia Biosciences located?

Arcadia Biosciences is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Arcadia Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Arcadia Biosciences from 12/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/19/2024.

When did Arcadia Biosciences pay the last dividend?

The last dividend was paid out on 12/19/2024.

What was the dividend of Arcadia Biosciences in the year 2023?

In the year 2023, Arcadia Biosciences distributed 0 USD as dividends.

In which currency does Arcadia Biosciences pay out the dividend?

The dividends of Arcadia Biosciences are distributed in USD.